Malin had raised €407 million in equity capital as of the end of June 2017

Listed life sciences company Malin, whose backers include the Irish State, is to raise as much as €31 million through a placing of new shares. The Du(...)

The Ireland Strategic Investment Fund is a 15 per cent shareholder in Malin, having invested €50 million in the group’s IPO.

Melinta Therapeutics, a company backed by Dublin-listed life sciences investment group Malin, is to gain a public listing on Nasdaq after agreeing a m(...)

The announcement marks Malin’s first new asset following its stock exchange debut earlier this year

Malin, an Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, has invested $35 million a(...)